COMPOSÉ DESTINÉ AU TRAITEMENT DE L'HÉPATITE C

• 收藏
• 分享

专利权人:

BRISTOL-MYERS SQUIBB COMPANY

发明人:

申请号：

EP12783457.0

公开号：

EP2768831B1

申请日:

2012.10.17

申请国别(地区):

EP

年份:

2015

代理人:

摘要：

The present invention provides (1aR,12bS)-8-cyclohexyl-11-fluoro-N-((1-methylcyclopropyl)sulfonyl)-1a-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl) carbonyl)-1,1a,2,12b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide (formula I), including pharmaceutically acceptable salts, as well as compositions and methods of using the compound. The compound has activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/